C-Path awards grant to UT Austin professor for groundbreaking antibiotic resistance research
Medicamente
Critical Path Institute (C-Path) Aug 13 2024 Critical Path Institute's (C-Path) Translational Therapeutics Accelerator (TRxA) announced today that Kenneth Keiler, Ph.D., Professor of Molecular Biosciences at the University of Texas at Austin, has been awarded a research grant for his innovative project titled "Inhibitors of the Gram-negative Cell Envelope Stress Response as Anti-Infectives and Antibiotics." This funding will support Dr. Keiler's original approach to addressing the critical
din zilele anterioare